The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.76

Today's change+0.81 +2.63%
Updated December 9 11:41 AM EST. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.76

Today's change+0.81 +2.63%
Updated December 9 11:41 AM EST. Delayed by at least 15 minutes.

Pfizer Inc crosses above 20-day moving average

Pfizer Inc is up sharply today, rallying (U.S.)$0.81 or 2.63% to (U.S.)$31.76 and crossing above its 20-day moving average. Over the last five days, shares have gained 0.40%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 11.69% during the last year.

Key company metrics

  • Open(U.S.) $31.11
  • Previous close(U.S.) $30.94
  • High(U.S.) $31.89
  • Low(U.S.) $31.09
  • Bid / Ask(U.S.) $31.75 / (U.S.) $31.76
  • YTD % change-1.63%
  • Volume12,734,979
  • Average volume (10-day)25,451,787
  • Average volume (1-month)32,994,485
  • Average volume (3-month)23,563,491
  • 52-week range(U.S.) $28.25 to (U.S.) $37.39
  • Beta0.89
  • Trailing P/E31.70×
  • P/E 1 year forward12.81×
  • Forward PEG1.93×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield3.78%
  • Trailing EPS(U.S.) $1.00
Updated December 9 11:41 AM EST. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 02, 201610/02/2016Jul 03, 201607/03/2016Apr 03, 201604/03/2016Dec 31, 201512/31/2015
Revenue13,04513,14713,00514,047
Total other revenue--------
Total revenue13,04513,14713,00514,047
Gross profit9,9639,97310,15410,675
Total cost of revenue3,0823,1742,8513,372
Total operating expense11,33810,5479,23414,079
Selling / general / administrative3,5593,4713,3855,048
Research & development1,8811,7481,7312,348
Depreciation / amortization9689611,006980
Interest expense (income), net operating--------
Unusual expense (income)2,1181,4535962,366
Other operating expenses, total-270-260-335-35
Operating income1,7072,6003,771-32
Interest income (expense), net non-operating-306-308-321-335
Gain (loss) on sale of assets473192
Other--------
Income before tax1,6042,4103,561-355
Income after tax1,3202,0353,026-167
Income tax, total284375535-188
Net income1,3202,0203,017-173
Total adjustments to net income-1-1-11
Net income before extra. items1,3202,0193,017-170
Minority interest0-16-9-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3192,0183,016-169
Inc. avail. to common incl. extra. items1,3192,0193,016-172
Diluted net income1,3192,0193,016-172
Dilution adjustment000--
Diluted weighted average shares6,1386,1376,2146,176
Diluted EPS excluding extraordinary itemsvalue per share0.210.330.49-0.03
Dividends per sharevalue per share0.300.300.300.28
Diluted normalized EPSvalue per share0.540.550.600.34